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ABSTRACT
Background Stroke is a risk factor for subsequent death
and dementia. Being able to identify subjects at
particular risk would be beneﬁcial to inform treatment
and patient management.
Methods Subjects aged over 75 years with incident
stroke were recruited. Subjects had a cognitive
assessment at 3 months post stroke to exclude
dementia, and had an MRI scan (n¼106) at that time.
Subjects were then followed longitudinally for incident
dementia and/or death.
Results Independent neuroimaging predictors of survival
to dementia were medial temporal atrophy (MTA;
p¼0.013) and the presence of thalamic infarcts
(p¼0.002). After inclusion of cognitive score in the
model, the signiﬁcance of MTA (p¼0.049) and thalamic
infarcts (p¼0.04) was reduced, with survival being best
predicted by baseline cognitive score (p¼0.004). The
only independent signiﬁcant predictor of survival to death
was MTA. Apart from thalamic infarcts, the NINDS/
AIREN neuroimaging criteria did not independently
predict survival to death or dementia.
Conclusions MTA was associated with shorter time to
dementia, suggesting a role for Alzheimer pathology in
the development of post stroke dementia.
INTRODUCTION
In people with stroke, dementia is common, and
may be a direct consequence of the stroke in 15%,
and be pre-existing in a further 10% of subjects.
1
However, stroke is also a risk factor for dementia in
the long term.
12
Risk factors which have been identiﬁed for
development of dementia after stroke include
medial temporal atrophy (MTA) and white matter
hyperintensities (WMH), as seen on T2 weighted
MRI imaging.
1
The criteria of the National Institute of Neuro-
logical Disorders and Stroke Association/Inter-
nationale pour la Recherche et al’Enseignement en
Neurosciences (NINDS/AIREN) are widely used to
diagnose vascular dementia (VaD).
3 Evidence of
cerebrovascular disease is required, and the report
includes speciﬁc criteria for the identiﬁcation of
vascular lesions on neuroimaging. We have previ-
ously found in a group of patients, including those
studied in this report, that the criteria did not
differentiate between post stroke subjects with and
without dementia,
4 and in this study we examined
whether they were predictive of dementia incidence
in the initially non-demented cohort.
Severity of WMH on neuroimaging is a signiﬁ-
cant predictor of long term survival after stroke.
5
Few studies have examined the role of MTA in long
term survival post stroke, although in the general
population both MTA and WMH predict lower
survival time in those attending memory clinics.
6e8
In this cohort of initially non-demented older
stroke survivors, we have previously demonstrated
associations between both WMH and MTA and
cognition within a few years of stroke.
9 10 Here we
look at the predictive ability of MTA, WMH and
the NINDS/AIREN neuroimaging criteria on
survival time over an 8 year period to dementia, and
to death. Based on our earlier ﬁndings and previous
literature, we hypothesised that MTA and WMH
would be signiﬁcant predictors of death and
dementia, whereas the NINDS/AIREN criteria
would not.
4
METHODS
Subjects
Stroke patients taking part in this imaging inves-
tigation were a previously described cohort
11 which
has been followed longitudinally. Older stroke
patients (n¼706) $75 years were pre-screened
consecutively between 2000 and 2002 from repre-
sentative hospital based stroke registers in Tyne-
side, Wearside and Teesside (UK) from seven
hospitals. Patients were over 75 years of age at the
time of the stroke, deﬁned using the WHO criteria.
Patients were comprehensively assessed at
3 months post stroke using a standardised battery
comprised of medical history, Mini-Mental State
Examination (MMSE) score, assessment of neuro-
logical deﬁcits, blood screen and review of CT brain
scan undertaken at the time of stroke, and were
excluded if they: (i) had signiﬁcant physical illness
and disabilities that precluded neuropsychological
evaluation (eg, visual impairment, aphasia, hemi-
paresis affecting the hand used for writing); (ii) had
a diagnosis of dementia according to DSM-IIIR
criteria; or (iii) declined to take part. Following
general practitioner approval and discussion of the
study, 355 of the original 706 subjects were eligible
for the post stroke survivor study. DSM-IIIR
criteria were used because they include a general
deﬁnition for dementia, unlike DSM-IV, which
presumes aetiology, and we were interested in post
stroke dementia regardless of cause. The total
number of MRI scans was limited by cost to
approximately 100, so not all subjects were
approached. Instead, eligible subjects were consec-
utively invited to have an MRI scan until 108 had
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Cerebrovascular diseaseagreed. The analysis here is a subset of a separate paper looking
at survival in the whole cohort with regard to cardiovascular risk
factors.
12 Subjects underwent an annual clinical and cognitive
assessment. The appropriate local research ethics committee
granted ethics approval for the study. Following full explanation
and discussion of the study, patients gave their consent to the
evaluations, with additional assent from the next of kin.
Neuropsychological testing
To evaluate global cognitive performance, we used the
Cambridge Cognitive Assessment-revised, section B (CAMCOG-
R),
13 which is a standardised paper and pencil test for global
cognition (maximum score, 105). It has subscores for several
cognitive domains, including executive function, and includes
the MMSE.
Diagnosis of dementia
On annual review, further evaluation for possible dementia
using DSM-IIIR dementia criteria was performed if a participant
was unable to complete an MMSE, or scored less than 24 on the
MMSE, or scored 2 or more points less on the MMSE than
12 months previously, or if any other signs of cognitive impair-
ment were apparent during their annual neuropsychological
evaluation. Criteria for dementia were applied by an experienced
dementia specialist, blind to results from MR imaging changes.
MRI acquisition
All patients were imaged using a 1.5 T GE Signa scanner
(General Electric, Milwaukee, USA). Coronally oriented whole
brain T1 weighted three-dimensional FSPGR data sets were
acquired (repetition time¼12.4 ms, echo time¼4.2 ms, inversion
time¼650 ms, pixel size 0.7830.78, 1.6 mm slice thickness, ﬂip
angle¼15
o) along with axial whole brain FLAIR images
(TR¼10000 ms, TE¼125 ms, TI¼2100 ms, slice thickness¼5
mm, interslice gap¼0.3 mm). Images were obtained at baseline.
Volume of white matter hyperintensities
Volume of WMH was obtained from the baseline MRI images
using previously validated automated software
14 Brieﬂy, spm99
(http://www.ﬁl.ion.ucl.ac.uk/spm) was used to segment the
brain from the FLAIR images. Volumes of WMH were then
determined by applying an intensity threshold of 1.45 times the
modal intensity for each slice to segment the WMH.
The accuracy of this was checked visually for each subject and
the total WMH volume in the whole brain was calculated.
Values in table 1 are WMH (in ml) for ease of interpretation,
however for the statistical analysis, we calculated the ratio of
WMH volume to total brain volume, and in order to produce
normally distributed data used a log transform.
MRI rating
Extent of medial temporal lobe atrophy (right and left) was
rated using a standardised scale
15 from hard copies of the base-
line T1 weighted coronal images. This scale rates atrophy (0,
absent; 1, minimal; 2, mild; 3, moderate; and 4, severe) based on
the width of the surrounding CSF spaces (temporal horn and
choroid ﬁssure) and the height of the hippocampal formation
(which includes the hippocampus proper, subiculum, and para-
hippocampal and dentate gyri). Left and right scores were
summed to give an overall combined MTA score (maximum
score 8). All scans were rated by consensus between three
trained and experienced raters (RB. JTO and EJB).
At the same time, the criteria for vascular lesions, as speciﬁed
by NINDS/AIREN, were also documented for each patient.
These are broadly classed under: (a) multiple large infarcts, (b)
strategic single infarcts (eg, angular gyrus) or thalamus or (c)
small vessel disease with extensive leukoaraiosis, or multiple
basal ganglia lacunes. Operational criteria for classifying such
lesions were suggested by van Straaten and colleagues.
16 WMHs
were rated from hard copies of FLAIR images acquired in the
axial plane. As part of the NINDS/AIREN criteria, those with
extensive periventricular WMHs and leukoencephalopathy
involving at least 25% of the total white matter were recorded.
All scan measurements and ratings were undertaken over the
baseline period, blind to clinical ﬁndings and before follow-up
data had been collected.
Statistical analysis
Statistical analysis was performed with SPSS (V.17.0). In order
to examine the associations between exposure to putative risk
factors for death or dementia, Cox proportional regression
analyses were used to obtain univariate proportional HRs for
each risk factor, using time (days) from index stroke to death
and dementia as the dependent variables. In the dementia
model, if a patient died, data were right censored. The date of
onset of dementia was assumed to be at the midpoint between
the two assessments where dementia status changed. HRs were
Table 1 Subject characteristics (n¼106)
Age at baseline (years) 79.8 (4.11)
Sex (F:M) 57:49
Deceased during follow-up (n (%)) 60 (57)
Developed dementia during follow-up (n (%)) 27 (25)
CAMCOG-R score 84.4 (8.53)
MMSE score 26.2 (2.69)
GDS score 3.37 (2.96)
WMH (ml) 2.08 (1.81)
MTA 2.71 (1.75)
Total brain volume (ml) 1009 (82.4)
Oxford Stroke Classiﬁcation
(LACS/PACS/TACS/POCS/unknown)
35/42/5/17/7
Any previous stroke/TIA (n¼103) (n (%)) 30 (29)
Previous stroke (residual disability) (n¼103) (n (%)) 15 (15)
Hypertension (n¼105) (n (%)) 64 (61)
Atrial ﬁbrillation (n¼105) (n (%)) 17 (16)
Diabetes mellitus (n¼101) (n (%)) 5 (5)
Current smoker (n (%)) 18 (17)
Ischaemic heart disease (n¼105) (n (%)) 36 (34)
Cortical lesion 40 mm or larger (n (%)) 25 (24)
AIREN bilateral anterior cerebral artery large infarct (n (%)) 0 (0)
AIREN bilateral large vessel infarct (n (%)) 3 (3)
AIREN large vesseldleft infarct (n (%)) 15 (14)
AIREN large vesseldright infarct (n (%)) 25 (24)
AIREN association areas large infarct (n (%)) 27 (26)
AIREN posterior cerebral artery stroke (n (%)) 11 (10)
AIREN bilateral thalamic infarct (n (%)) 6 (6)
AIREN basal ganglia small vessel disease (n (%)) 65 (61)
AIREN periventricular WMH (n (%)) 43 (41)
AIREN frontal WMH (n (%)) 47 (44)
AIREN WMH >25% (n (%)) 27 (26)
AIREN any (n (%)) 102 (96)
Any thalamic infarct (n (%)) 40 (38)
Values are mean (SD) or n (%).
AIREN, relevant imaging change meets imaging criteria as speciﬁed in the National
Institute of Neurological Disorders and Stroke Association/Internationale pour la
Recherche et al’Enseignement en Neurosciences (NINDS/AIREN) criteria; CAMCOG-R,
Cambridge Cognitive Assessment-revised; GDS, Geriatric Depression 15 point Scale;
LACS/PACS/TACS/POCS, lacunar/partial anterior/total anterior/posterior syndrome;
MTA, medial temporal lobe atrophy rating; MMSE, Mini-Mental State Examination; TIA,
transient ischaemic attack; WMH, white matter hyperintensity volume.
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Cerebrovascular diseasegiven according to presence or absence of the risk factor, or per
point on quantitative scales, as appropriate. There were no
missing data in the variables we examined.
Following identiﬁcation in univariate models, signiﬁcant
predictors of death and dementia were entered into a multivar-
iate Cox regression model. Where similar features were described
by more than one signiﬁcant predictor, the predictor with the
higher level of signiﬁcance in univariate analyses was entered
into multivariate analyses, in order to avoid coaggregation of
predictors (eg, WMH volume rather than AIREN WMH >25%).
Multivariate Cox models were examined to see if the propor-
tional hazard assumption was met (using the R program V2.10,
http://cran.r-project.org/) by investigating the scaled Schoenfeld
residuals graphically and correlating the residuals against time.
Non-linearity was investigated using graphical inspection of
Martingale residuals plotted against covariates.
RESULTS
Of the 108 subjects who underwent MRI, two moved during the
scan, leaving 106 successful scans for analysis. Table 1 shows the
demographics of the study group. Subjects were followed-up for
a median of 3.18 (IQR 4.78) years to last dementia assessment,
and a median of 6.62 (IQ range 4.05) years for deaths. All
subjects (apart from two) were followed-up until either death or
9 years after initiation of the study. Of those whose ﬁnal status
was ‘without dementia’ (n¼79), there were 55 (71%) who had
an assessment of dementia within 1 year of their last recorded
vital status. There were no signiﬁcant differences between those
with successful MRI (n¼106) versus those who did not have an
MRI scan (n¼249) in age (79.8 (SD 4.1) vs 80.3 (SD 4.1); t¼1.2,
p¼0.25), CAMCOG-R score (84.4 (SD 8.5) vs 85.3 (SD 9.1);
t¼0.914, p¼0.36), sex (F/M¼57/49 vs 135/114; c
2¼1.90,
p¼0.17) or Oxford Community Stroke Classiﬁcation (lacunar/
partial anterior/total anterior/posterior syndrome/unknown
35/42/5/17/7 (33/40/5/16/7%) vs 81/103/14/32/19 (33/41/6/
13/8%; c
2¼0.829, p¼0.94).
Table 2 presents results of univariate Cox survival analysis for
time to dementia. Signiﬁcant neuroimaging predictors of shorter
time to dementia onset were MTA and volume of WMH, along
with age, sex and both CAMCOG-R and MMSE scores at
baseline. Both MTA (r¼ 0.271; p¼0.005) and WMH
(r¼ 0.253; p¼0.009) were signiﬁcantly correlated with baseline
CAMCOG-R score. Of the NINDS/AIREN neuroimaging
criteria, the presence of bilateral thalamic infarcts along with
WMH predicted survival. In a Cox multivariate model with age,
and the signiﬁcant neuroimaging variables, independent predic-
tors of survival time to dementia were MTA (p¼0.031, HR¼1.34
(95% CI 1.03 to 1.75)), WMH volume (p¼0.037, HR¼1.90 (1.04
to 3.48)) and the presence of thalamic lesions (p¼0.004, 5.20 (1.7
to 15.9)). Examining the model, there was no non-linearity in
the continuous variables, however, there was evidence of a non-
proportional hazard for age. We therefore repeated the analysis,
stratifying for age (in groups of 75e79 years (n¼59), 80e84
years (n¼32) and age >85 years (n¼15)). Results of this are
shown in table 3 (model ﬁt c
2¼24.0, p<0.001).
With the addition of CAMCOG-R score to the model (table 3,
model ﬁt c
2¼34.4, p<0.001), the signiﬁcant predictors were
CAMCOG-R (p¼0.004), thalamic lesions (p¼0.040) and MTA
(p¼0.049). Figure 1A shows a univariate survival curve of
CAMCOG-R versus time to dementia. Using MMSE rather than
CAMCOG-R produced almost identical results, with MMSE
strongly predicting survival in the multivariate analysis
(p¼0.004).
Table 4 has the results of the Cox univariate survival analysis
for time to death. Signiﬁcant predictors were age, MTA and
CAMCOG-R score. None of the NINDS/AIREN neuroimaging
variables was signiﬁcantly associated with survival time to death
(data not shown). In a multivariate model with age and MTA
(table 5), survival time was predicted by MTA (c
2 for model ﬁt
10.3, p¼0.006). There was no evidence of non-linearity or non-
proportional hazards in the model. Adding CAMCOG-R score
did not signiﬁcantly improve the model (change in model c
2 1.8,
p¼0.2). Figure 1B shows a survival curve of MTA versus survival
to death.
DISCUSSION
Our principal ﬁnding was that in this older cohort of non-
demented stroke survivors, the presence of MTA at baseline was
Table 2 Univariate Cox survival model for time to dementia
p Value HR (95% CI)
Age (years) 0.003 1.12 (1.04 to 1.21)**
Male sex 0.806 0.909 (0.425 to 1.95)
MTA 0.003 1.43 (1.13 to 1.80)**
Log (WMH/TBV) 0.001 2.42 (1.41 to 4.16)**
Total brain volume (ml) 0.183 0.995 (0.989 to 1.00)
Cortical lesion 40 mm or larger 0.551 0.724 (0.250 to 2.10)
AIREN association areas 0.695 1.19 (0.502 to 2.81)
AIREN post-cerebral artery infarct 0.707 0.759 (0.179 to 3.21)
AIREN basal ganglia 0.938 1.03 (0.472 to 2.25)
AIREN frontal WMH 0.680 1.17 (0.550 to 2.50)
AIREN periventricular WMH 0.013 2.65 (1.23 to 5.74)*
AIREN bilateral thalamic infarct <0.001 6.47 (2.42 to 17.3)**
AIREN large vesseldleft 0.874 1.09 (0.376 to 3.16)
AIREN large vesseldright 0.457 0.668 (0.231 to 1.93)
AIREN bilateral large vessel 0.524 0.047 (0.000 to 580)
AIREN WMH >25% 0.025 2.41 (1.11 to 5.19)*
AIREN sum of scores 0.024 1.40 (1.05 to 1.87)*
Any thalamic infarct 0.436 1.35 (0.633 to 2.89)
CAMCOG-R <0.001 0.902 (0.865 to 0.941)**
MMSE <0.001 0.716 (0.620 to 0.826)**
*p<0.05; **p<0.01.
AIREN, relevant imaging change meets imaging criteria as speciﬁed in the National
Institute of Neurological Disorders and Stroke Association/Internationale pour la
Recherche et al’Enseignement en Neurosciences (NINDS/AIREN) criteria; CAMCOG-R,
Cambridge Cognitive Assessment-revised; MMSE, Mini-Mental State Examination;
MTA, medial temporal lobe atrophy rating; TBV, total brain volume; WMH, white matter
hyperintensity volume.
Table 3 Multivariate Cox model of survival to dementia with
signiﬁcant neuroimaging predictors stratiﬁed by age, and with
addition of cognitive score
p Value HR (95% CI)
Signiﬁcant neuroimaging predictor
MTA 0.013 1.42 (1.08 to 1.86)
Log (WMH/TBV) 0.060 1.81 (0.976 to 3.34)
AIREN bilateral thalamic lesions 0.002 8.49 (2.17 to 33.2)
Signiﬁcant neuroimaging + cognitive score predictors
MTA 0.049 1.32 (1.00 to 1.75)
Log (WMH/TBV) 0.146 1.59 (0.851 to 2.96)
AIREN bilateral thalamic lesions 0.040 4.11 (1.07 to 15.8)
CAMCOG-R 0.004 0.929 (0.884 to 0.976)
AIREN, relevant imaging change meets imaging criteria as speciﬁed in the National
Institute of Neurological Disorders and Stroke Association/Internationale pour la
Recherche et al’Enseignement en Neurosciences (NINDS/AIREN) criteria; CAMCOG-R,
Cambridge Cognitive Assessment-revised; MTA, medial temporal lobe atrophy rating;
TBV, total brain volume; WMH, white matter hyperintensity volume.
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Cerebrovascular diseaseassociated with shorter survival time to subsequent onset of
dementia, suggesting a role for Alzheimer’s type pathology as
a cause of post stroke dementia. However, baseline CAMCOG-R
score was a much stronger predictor of survival to dementia. We
did not see any association between dementia and large vessel
stroke although the numbers with AIREN large vessel infarcts
were relatively small so the study may have been underpowered
to detect such an association. Our ﬁndings are in keeping with
previous studies in generally younger stroke patients
1 showing
the inﬂuence of MTA and WMH on post stroke dementia. We
examined the role of the NINDS/AIREN neuroimaging criteria
for VaD and, apart from thalamic lesions and WMHs, did not
ﬁnd any increased rate of dementia in those meeting the indi-
vidual criteria. This is in keeping with our previous study in
which we found that there was no difference between the
NINDS/AIREN neuroimaging criteria in those with acute post
stroke dementia versus those without.
4 The results suggest that
post stroke dementia is associated more strongly with small
vessel than large vessel stroke, in agreement with the ﬁndings of
Staekenborg
17 who reported that the majority of VaD cases had
small vessel disease. This is also consistent with the ﬁnding that
the prevalence of post stroke dementia, albeit in younger
subjects, was associated with lacunar infarcts in a 24 year
population based study.
18
We also found a relationship between bilateral thalamic
lesions and dementia, which supports previous work suggesting
such a link.
19e21 The presence of any thalamic infarct was not
a signiﬁcant predictor of cognitive decline (table 2), suggesting
that more extensive thalamic involvement is required before
cognition is affected. However, our ﬁnding must be treated with
caution as only six subjects had bilateral thalamic lesions.
The best predictor of survival time to post stroke dementia
was cognitive score 3 months post stroke. Other studies have
also found this to be the case in younger subjects.
22 In the larger
cohort from which this imaging study was drawn, cognitive
score, along with cardiovascular risk factors, predicted survival
time to dementia.
12 This suggests that poor cognitive status
shortly after stroke is indicative of ongoing cognitive decline, or
that there is a threshold of cognitive damage which it is difﬁcult
to recover from. As this was an incident study, we do not have
information about the cognitive status of participants before the
stroke, and it is possible that some mild cognitive impairment
preceded the stroke, although we did rule out dementia
immediately post stroke.
23 24
We found that MTA was the best predictor of survival time to
death whereas WMH did not predict survival time. This is
contrary to a previous study which reported an association with
WMH,
5 however, differences between the studies are that our
subjects were on average 10 years older. The mechanism for this
association of MTA with survival is unclear although the
hippocampus is relatively sensitive to hypoperfusion so MTA
Figure 1 Univariate survival. (A) Time to dementia by Cambridge
Cognitive Assessment-revised (CAMCOG-R) score in three groupsd
CAMCOG-R >90 (n¼31), CAMCOG-R 82e90 (n¼38) and CAMCOG-R
<82 (n¼37). (B) Time to death by medial temporal atrophy (MTA) in
two groupsdMTA <3( n ¼50) and MTA $3( n ¼56).
Table 4 Univariate Cox model of survival to death
p Value HR
Age (years) 0.012 1.08 (1.02 to 1.15)*
Male sex 0.40 1.25 (0.751 to 2.08)
MTA 0.009 1.23 (1.06 to 1.44)**
Log (WMH/TBV) 0.288 1.18 (0.870 to 1.60)
Total brain volume (ml) 0.142 0.997 (0.993 to 1.00)
CAMCOG-R 0.020 0.967 (0.939 to 0.995)*
MMSE 0.053 0.915 (0.836 to 1.00)
*p<0.05; **p<0.01.
CAMCOG-R, Cambridge Cognitive Assessment-revised; MTA, medial temporal lobe
atrophy rating; MMSE, Mini-Mental State Examination; TBV, total brain volume; WMH,
white matter hyperintensity volume.
Table 5 Multivariate Cox model of survival to death with age and
signiﬁcant neuroimaging predictors and with CAMCOG-R score also
added
p Value HR
Age + signiﬁcant neuroimaging predictors
Age (years) 0.072 1.06 (0.995 to 1.13)
MTA 0.039 1.19 (1.01 to 1.40)
Age + signiﬁcant neuroimaging + CAMCOG-R score predictors
Age (years) 0.156 1.05 (0.983 to 1.12)
MTA 0.075 1.17 (0.985 to 1.38)
CAMCOG-R 0.163 0.978 (0.949 to 1.01
CAMCOG-R, Cambridge Cognitive Assessment-revised; MTA, medial temporal lobe
atrophy rating.
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Cerebrovascular diseasemay be a proxy measure of the general level of hypoperfusion.
Untreated hypertension has been shown to be associated with
MTA
25 and perhaps the presence of poorly controlled vascular
risk factors contributed to survival. Although we did not ﬁnd
total brain volume to predict survival, it is possible that atrophy
in strategic locations in the brain might contribute. Future
research should look at associations between survival and
regional atrophy throughout the brain using techniques such as
voxel based morphometry.
Although our subsample of 106 subjects with MRI was
representative of the 355 in the main cohort, there is the
possibility of selection biasdthose who declined participation
may have had more severe stroke (or speciﬁc types of stroke),
and although we have details on survival to death on practically
all subjects, the follow-up to dementia was less complete due to
difﬁculty in arranging a cognitive assessment or the patients
died before dementia was noted. We assessed people 3 months
after stroke in order to minimise the acute effects of stroke on
cognitive assessment but this may have resulted in selection bias
against those who died in the 3 months. We had relatively small
numbers of patients with large vessel stroke, and there may be
a selection bias here, with those included being unrepresentative
of large vessel stroke patients in general.
WMH had no signiﬁcant association with dementia when the
model was stratiﬁed according to age. It is possible that age
related changes to the T1 value of the brain meant that the
brightness of WMH (and hence the automatically segmented
volume of WMH) varied with age.
A limitation of the study is that we did not have information
regarding cognitive status before stroke, as it is likely that the
stroke will have caused some decline in cognitive function, even
though we excluded subjects with dementia. It is probable that
cognitive ability before stroke would be associated with longer
survival to dementia due to mechanisms associated with
cognitive reserve.
Recent research has suggested that microbleeds (areas of
hypointensity on T2* weighted MR images) may be predictive
of mortality and cognitive decline.
6 26 Microbleeds are common
in both stroke and Alzheimer’s disease. A limitation of this
study is that we could not analyse microbleeds with the imaging
sequences we acquired. Future research should investigate to
what extent microbleeds additionally contribute to survival.
Strengths of the study include a well characterised group of older
post stroke survivors who did not have dementia immediately
after stroke and who were followed-up for an extensive period
of time.
In summary, we found that MTA and WMH were associated
with incidence of dementia but that cognitive status 3 months
post stroke was the best predictor of survival time to dementia.
If conﬁrmed in other studies, this would be a useful clinical
indicator of likely decline in older stroke survivors.
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